Tumor Transcriptomics Market to be dominated by Lung Cancer through 2027
Growing healthcare expenditure in developing countries and the rise in adoption of advanced genome sequencing tools are driving the demand for the global tumor transcriptomics market in the forecast period, 2023-2027. According to TechSci Research report, “ Tumor Transcriptomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 ” , the global tumor transcriptomics market is anticipated to grow at a formidable rate in the forecast period, 2023-2027. The improvements in the healthcare infrastructure, rise in the number of biopharmaceutical companies, and approvals and launch of microarrays are the primary factors driving the demand for the global tumor transcriptomics market. Tumor transcriptomics is a type of RNA Study and includes assessments of explorations of noncoding RNAs, the discovery of novel transcripts, alternative splicing and alternative polyadenylation, and identification of fusion transcripts. It is considered a valuable t...